Newly-released Hospital-acquired Infection Control Market analysis report by Future Market Insights shows that global sales of Hospital-acquired Infection Control in 2023 were held at US$ 6.5 Billion. With a CAGR of 7% from 2023 to 2033, the market is projected to reach US$ 12.7 Billion by 2033. The market is expected to generate significant revenue through Hospitals and Intensive care Units, accounting for a CAGR of 7.6%.
| Attribute | Details |
|---|---|
| Global Hospital-Acquired Infection Control Market (2023) | US$ 6.5 Billion |
| Global Hospital-Acquired Infection Control Market (2033) | US$ 12.7 Billion |
| Global Hospital-Acquired Infection Control Market CAGR (2023 to 2033) | 7% |
| USA Hospital-Acquired Infection Control Market CAGR (2023 to 2033) | 8.1% |
| Key Companies Profiled |
|
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As per the Hospital-acquired Infection Control industry research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2018 to 2022, the market value of the Hospital-acquired Infection Control market increased at a CAGR of 6.5%, wherein, countries such as the USA, the United kingdom, China, South Korea and Japan held significant share in the global market. Owing to this, the market is projected to grow at a CAGR of 7.6% over the coming 10 years.
The frequent occurrence of hospital-acquired infections, the growing proportion of surgical procedures, the rising geriatric population and the increasing prevalence of chronic diseases, technological advancements in sterilization equipment, and the growing awareness of environmental and personal hygiene are the key factors driving the growth of the Hospital-acquired infection control market.
The growing use of e-beam sterilization and the reintroduction of ethylene oxide sterilization are further expected to swell the demand for hospital-acquired infection control.
The percentage of surgeries performed worldwide has increased significantly over the years. Every year, approximately 235 million complex surgical procedures are performed worldwide, according to the WHO. This is due to an increase in the prevalence of obesity and other lifestyle diseases, an increase in the geriatric population, and an increase in the incidence of spinal injuries and sports-related injuries.
With the growth in the number of surgical procedures conducted, the demand for various surgical equipment and medical devices is also surging. The proven benefits of sterilized product lines and growing awareness about their effectiveness in healthcare settings are expected to drive demand for hospital-acquired infection services.
Ethylene oxide is one of the most effective gaseous sterilizing agents for high-temperature-sensitive instruments, such as plastic equipment and instruments with electrical components. The CDC, on the other hand, has stated that chronic exposure to ethylene oxide in the workplace can cause cancer. Furthermore, ethylene oxide sterilization can irritate the skin and mucous membranes, causing CNS abnormalities in humans.
Acute exposure to EtO gas, on the other hand, can cause respiratory irritation, lung injury, headache, nausea, vomiting, diarrhea, shortness of breath, and cyanosis. EtO degrades in the atmosphere as well, reacting with photochemically generated hydroxyl radicals. Regulatory frameworks have been established in several countries to govern the use of EtO in specific sterilization applications.
Principal Consultant
Due to rising demand for Hospital-acquired Infection Control methods in developing nations, particularly Japan, the market in the Asia Pacific is projected to account for a CAGR of over 7% during the forecast period.
The regional market is growing due to the extensive usage of Hospital-acquired infection controls and increased awareness of general health and fitness among the working-class population.
The USA stands as one of the largest markets for hospital-acquired infection control. The market growth in the region is characterized by rising demand for and adoption of sterilization and disinfection products and services as a result of consumers' increased emphasis on healthy lifestyles and disease prevention.
The increase in the geriatric population in the coming years, as well as the subsequent rise in the incidence of chronic diseases, the need for Hospital-acquired infection control to reduce the prevalence of HAIs, and the implementation of favorable government initiatives and stringent sterilization and disinfection regulations, are driving the Hospital-acquired infection market in the country.
The market in the United kingdom is expected to reach a valuation of US$ 527 Million by 2033. Growing with a CAGR of 5.8% in the forecast period, the market in the country is projected to garner an absolute dollar opportunity of around US$ 227.7 Million.
In Japan, the market is expected to grow at a CAGR of 6.8% from 2023 to 2033, reaching around US$ 490.6 Million by 2033. The market in the country is expected to gross an absolute dollar opportunity of US$ 238 Million during the forecast period.
The market in South Korea is expected to reach a valuation of around US$ 262 Million by 2033, growing at a CAGR of 6.6% from 2023 to 2033. The market in the country is expected to witness an absolute dollar opportunity of around US$ 123.7 Million.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Hospitals and intensive care units, ambulatory surgical & diagnostic centers, nursing homes, and maternity centers, as well as other end users, make up the Hospital-acquired infection control market. The market revenue through the ambulatory surgery and diagnostic centers category is predicted to increase at a significant CAGR throughout the projection period.
The large contribution to the market revenue through ambulatory surgical and diagnostic centers is due to the rising prevalence of HAIs, and increasing acceptance of single-use medical devices in these healthcare facilities.
The key players in the market include Steris Plc, Sotera Health Company, Getinge AB, Advanced Sterilization Products, Ecolab Inc., 3M Company, Matachana Group, MMM Group, Belimed AG, and Reckitt Benckiser.
Some of the recent developments of key Hospital-acquired Infection Control providers are as follows:
Similarly, recent developments related to companies offering Hospital-acquired Infection Control have been tracked by the team at Future Market Insights, which is available in the full report.
Market analysts predict that by 2023 it may be worth US$ 6.5 billion.
Sales soared considerably at an HCAGR of 6.5% from 2018 to 2022.
Through 2033, the market is projected to maintain its momentum at a CAGR of 7%.
By 2033, it is expected that the size of the global market will approach US$ 12.7 billion.
The Asia Pacific market is scheduled to expand at a CAGR of 7% through 2033.
United Kingdom’s market is poised to develop at a CAGR of 5.8% through 2033.
1. Executive Summary
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on District Cooling Demand
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Million)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background and Foundation Data Points
4.1. Global Market (US$ Million)
4.2. Market Opportunity Assessment (US$ Million)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Global Market Growth
4.5.3. District Cooling Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Market Demand Analysis 2018 to 2022 and Forecast, 2023 to 2033
6.1. Historical Market Analysis, 2018 to 2022
6.2. Current and Future Market Projections, 2023 to 2033
6.3. Y-o-Y Growth Trend Analysis
7. Global Market Value Analysis 2018 to 2022 and Forecast, 2023 to 2033
7.1. Historical Market Value (US$ Million) Analysis, 2018 to 2022
7.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Component
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Million) Analysis By Component, 2018 to 2022
8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Component, 2023 to 2033
8.3.1. Equipment
8.3.1.1. Sterilization Equipment
8.3.1.2. Disinfection Equipment
8.3.2. Consumables
8.3.2.1. Disinfectants
8.3.2.2. Sterilization Consumables
8.3.2.3. Others
8.3.3. Services
8.4. Market Attractiveness Analysis By Component
9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-user
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) Analysis By End-user, 2018 to 2022
9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End-user, 2023 to 2033
9.3.1. Hospitals and Intensive Care Units
9.3.2. Ambulatory Surgical and Diagnostic Centers
9.3.3. Others
9.4. Market Attractiveness Analysis By End-user
10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
10.1. Introduction
10.2. Historical Market Size (US$ Million) Analysis By Region, 2018 to 2022
10.3. Current Market Size (US$ Million) & Analysis and Forecast By Region, 2023 to 2033
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. Asia Pacific
10.3.5. Middle East and Africa (MEA)
10.4. Market Attractiveness Analysis By Region
11. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
11.1. Introduction
11.2. Pricing Analysis
11.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033
11.4.1. By Country
11.4.1.1. USA
11.4.1.2. Canada
11.4.1.3. Rest of North America
11.4.2. By Component
11.4.3. By End-user
11.5. Market Attractiveness Analysis
11.5.1. By Country
11.5.2. By Component
11.5.3. By End-user
12. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033
12.4.1. By Country
12.4.1.1. Brazil
12.4.1.2. Mexico
12.4.1.3. Rest of Latin America
12.4.2. By Component
12.4.3. By End-user
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Component
12.5.3. By End-user
13. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033
13.4.1. By Country
13.4.1.1. Germany
13.4.1.2. France
13.4.1.3. United kingdom
13.4.1.4. Italy
13.4.1.5. Benelux
13.4.1.6. Nordic Countries
13.4.1.7. Rest of Europe
13.4.2. By Component
13.4.3. By End-user
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Component
13.5.3. By End-user
14. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033
14.4.1. By Country
14.4.1.1. China
14.4.1.2. Japan
14.4.1.3. South Korea
14.4.1.4. Rest of Asia Pacific
14.4.2. By Component
14.4.3. By End-user
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Component
14.5.3. By End-user
15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
15.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033
15.4.1. By Country
15.4.1.1. GCC Countries
15.4.1.2. South Africa
15.4.1.3. Turkey
15.4.1.4. Rest of Middle East and Africa
15.4.2. By Component
15.4.3. By End-user
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Component
15.5.3. By End-user
16. Key Countries Market Analysis 2018 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.1.1. Market Value Proportion Analysis, By Key Countries
16.1.2. Global Vs. Country Growth Comparison
16.2. US Market Analysis
16.2.1. Value Proportion Analysis by Market Taxonomy
16.2.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.2.2.1. By Component
16.2.2.2. By End-user
16.3. Canada Market Analysis
16.3.1. Value Proportion Analysis by Market Taxonomy
16.3.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.3.2.1. By Component
16.3.2.2. By End-user
16.4. Mexico Market Analysis
16.4.1. Value Proportion Analysis by Market Taxonomy
16.4.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.4.2.1. By Component
16.4.2.2. By End-user
16.5. Brazil Market Analysis
16.5.1. Value Proportion Analysis by Market Taxonomy
16.5.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.5.2.1. By Component
16.5.2.2. By End-user
16.6. Germany Market Analysis
16.6.1. Value Proportion Analysis by Market Taxonomy
16.6.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.6.2.1. By Component
16.6.2.2. By End-user
16.7. France Market Analysis
16.7.1. Value Proportion Analysis by Market Taxonomy
16.7.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.7.2.1. By Component
16.7.2.2. By End-user
16.8. Italy Market Analysis
16.8.1. Value Proportion Analysis by Market Taxonomy
16.8.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.8.2.1. By Component
16.8.2.2. By End-user
16.9. BENELUX Market Analysis
16.9.1. Value Proportion Analysis by Market Taxonomy
16.9.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.9.2.1. By Component
16.9.2.2. By End-user
16.10. UK Market Analysis
16.10.1. Value Proportion Analysis by Market Taxonomy
16.10.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.10.2.1. By Component
16.10.2.2. By End-user
16.11. Nordic Countries Market Analysis
16.11.1. Value Proportion Analysis by Market Taxonomy
16.11.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.11.2.1. By Component
16.11.2.2. By End-user
16.12. China Market Analysis
16.12.1. Value Proportion Analysis by Market Taxonomy
16.12.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.12.2.1. By Component
16.12.2.2. By End-user
16.13. Japan Market Analysis
16.13.1. Value Proportion Analysis by Market Taxonomy
16.13.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.13.2.1. By Component
16.13.2.2. By End-user
16.14. South Korea Market Analysis
16.14.1. Value Proportion Analysis by Market Taxonomy
16.14.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.14.2.1. By Component
16.14.2.2. By End-user
16.15. GCC Countries Market Analysis
16.15.1. Value Proportion Analysis by Market Taxonomy
16.15.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.15.2.1. By Component
16.15.2.2. By End-user
16.16. South Africa Market Analysis
16.16.1. Value Proportion Analysis by Market Taxonomy
16.16.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.16.2.1. By Component
16.16.2.2. By End-user
16.17. Turkey Market Analysis
16.17.1. Value Proportion Analysis by Market Taxonomy
16.17.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.17.2.1. By Component
16.17.2.2. By End-user
16.17.3. Competition Landscape and Player Concentration in the Country
17. Market Structure Analysis
17.1. Market Analysis by Tier of Companies
17.2. Market Concentration
17.3. Market Share Analysis of Top Players
17.4. Market Presence Analysis
17.4.1. By Regional footprint of Players
17.4.2. Product footprint by Players
18. Competition Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Competition Deep Dive
18.3.1. Olympus Corporation
18.3.1.1. Overview
18.3.1.2. Product Portfolio
18.3.1.3. Sales Footprint
18.3.1.4. Strategy Overview
18.3.2. BD
18.3.2.1. Overview
18.3.2.2. Product Portfolio
18.3.2.3. Sales Footprint
18.3.2.4. Strategy Overview
18.3.3. Getinge AB
18.3.3.1. Overview
18.3.3.2. Product Portfolio
18.3.3.3. Sales Footprint
18.3.3.4. Strategy Overview
18.3.4. Xenex Disinfection Services Inc.
18.3.4.1. Overview
18.3.4.2. Product Portfolio
18.3.4.3. Sales Footprint
18.3.4.4. Strategy Overview
18.3.5. 3M
18.3.5.1. Overview
18.3.5.2. Product Portfolio
18.3.5.3. Sales Footprint
18.3.5.4. Strategy Overview
19. Assumptions and Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports
Hospital-acquired Infection Control Market
